Nucleus Life Trust Revised's most recent trade in RPG Life Sciences Ltd. was a Acquisition of 4,412 Equity Shares done at an average price of Rs. 2207.2 . Disclosure was reported to the exchange on March 12, 2025 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for Nucleus Life Trust Revised in the Trendlyne database.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RPG Life Sciences | Nucleus Life Trust (Revised) | Promoter Group | Acquisition | 12 Mar 2025 | 4,412 | 8,904,393 (53.84%) | 0.03% | 2207.2 | 9,738,144 | 29 Nov 2024 29 Nov 2024 |
Insider Trading | Equity Shares | Market Purchase |
| RPG Life Sciences | Nucleus Life Trust (Revised) | Promoter Group | Acquisition | 12 Mar 2025 | 306 | 8,899,981 (53.81%) | 0.00% | 2085.7 | 638,232 | 28 Nov 2024 29 Nov 2024 |
Insider Trading | Equity Shares | Market Purchase |
| RPG Life Sciences | Nucleus Life Trust (Revised) | Promoter Group | Acquisition | 12 Mar 2025 | 1,859 | 8,899,675 (53.81%) | 0.01% | 2100.2 | 3,904,266 | 28 Nov 2024 29 Nov 2024 |
Insider Trading | Equity Shares | Market Purchase |
| RPG Life Sciences | Nucleus Life Trust (Revised) | Promoter Group | Acquisition | 12 Mar 2025 | 3,048 | 8,907,441 (53.86%) | 0.02% | 2188.0 | 6,668,879 | 29 Nov 2024 29 Nov 2024 |
Insider Trading | Equity Shares | Market Purchase |